Abstract
The incidence of biotinidase deficiency in Turkey is currently one of the highest in the world. To expand upon the information about the biotinidase gene (BTD) variations in Turkish patients, we conducted a mutation screening in a large series (n = 210) of probands with biotinidase deficiency, using denaturing high-performance liquid chromatography and direct DNA sequencing. The putative effects of novel mutations were predicted by computational program. Twenty-six mutations, including six novels (p.C143F, p.T244I, c.1212-1222del11, c.1320delG, p.V457L, p.G480R) were identified. Nine of the patients were symptomatic at the initial clinical assessment with presentations of seizures, encephalopathy, and lactic acidemia. The most common mutation in this group of symptomatic patients was c.98-104 del7ins3. Among the screened patients, 72 have partial and 134 have profound biotinidase deficiency (BD) of which 106 are homozygous for BTD mutations. The common mutations (p.R157H, p.D444H, c.98-104del7ins3, p.T532M) cumulatively accounted for 72.3 % of all the mutant alleles in the Turkish population.
Conclusion: The identification of common mutations and hot spot regions of the BTD gene in Turkish patients is important for mutation screening in the Turkish population and helps to ascertain carriers, may have impact on genetic counseling and implementing prevention programs.
What is Known • The screened group is one of the largest series (n = 210) of BD probands in childhood and provides reliable information about the BTD gene mutation spectrum in the Turkish population. |
What is New • This study adds six novel mutations, their phenotypic presentations and putative effects to the literature. • Seventeen of the detected mutant alleles caused early symptoms. |
Similar content being viewed by others
Abbreviations
- ACC-1:
-
Acetyl-CoA carboxylase-1
- ACC-2:
-
Acetyl-CoA carboxylase-2
- BD:
-
Biotinidase deficiency
- BTD:
-
Biotinidase enzyme
- dHPLC:
-
Denaturing high-performance liquid chromatography
- MCC:
-
Methylcrotonyl-CoA carboxylase
- PC:
-
Pyruvate carboxylase
- PCC:
-
Propionyl-CoA carboxylase
- PCR:
-
Polymerase chain reaction
- PS-DVB:
-
Polystyrene-divinyl-benzene
- TEAA:
-
Triethylammonium acetate
References
Al-Shamsi A, Hertecant JL, Al-Hamad S, Souid AK, Al-Jasmi F (2014) Mutation spectrum and birth prevalence of inborn errors of metabolism among Emiratis. Sultan Qaboos Univ Med J 14(1):42–49
Anonymous (2011) Newborn screening programs in Turkey. Ministry of Health, Health of mother-child and family plannig general managment
Baumgartner ER, Suormala T (2000) Biotin responsive multiple carboxylase deficiency. In: Fernandes J, Saudubray JM, Van den Berghe G (eds) Inborn metabolic diseases: diagnosis and treatment, 3rd edn. Springer, New York, p 276
Baykal T, Gokcay G, Gokdemir Y, Demir F, Seckin Y, Demirkol M, Jensen K, Wolf B (2005) Asymptomatic adults and older siblings with biotinidase deficiency ascertained by family studies of index cases. J Inherit Metab Dis 28(6):903–912. doi:10.1007/s10545-005-0161-3
Chedrawi AK, Ali A, Al Hassnan ZN, Faiyaz-Ul-Haque M, Wolf B (2008) Profound biotinidase deficiency in a child with predominantly spinal cord disease. J Child Neurol 23:1043–1048. doi:10.1177/0883073808318062
Cole H, Reynolds TR, Buck GB, Lockyer JM, Denson T, Spence JE, Hymes J, Wolf B (1994) Human serum biotinidase: cDNA cloning, sequence and characterization. J Biol Chem 269:6566–6570
Cowan TM, Blitzer M, Wolf B (2010) Technical standards and guidelines for the diagnosis of biotinidase deficiency. Genet Med 12(7):464–470. doi:10.1097/GIM.0b013e3181e4cc0f
Dobrowolski SF, Angeletti J, Banas RA, Naylor EW (2003) Real time PCR assays to detect common mutations the biotinidase gene and application of mutational analysis to newborn screening for biotinidase deficiency. Mol Genet Metab 78:100–107. doi:10.1016/S1096-7192(02)00231-7
Hernandez-Vazquez A, Wolf B, Pindolia K, Ortega-Cuellar D, Hernandez-Gonzalez R, Heredia-Antunez A, Ibarra-Gonzalez I, Velazquez-Arellano A (2013) Biotinidase knockout mice show cellular energy deficit and altered carbon metabolism gene expression similar to that of nutritional biotin deprivation: clues for the pathogenesis in the human inherited disorder. Mol Genet Metab 110:248–254. doi:10.1016/j.ymgme.2013.08.018
Knight HC, Reynolds TR, Meyers GA, Pomponio RJ, Buck GA, Wolf B (1998) Structure of human biotinidase gene. Mamm Genome 9:327–330
Küry S, Ramaekers V, Bezieau S, Wolf B (2012) Clinical utility gene card for: biotinidase deficiency. Eur J Hum Genet. doi:10.1038/ejhg.2012.28
Laszlo A, Schuler EA, Sallay E, Endreffy E, Somagyi C, Varkonyi A, Havass Z, Jensen K, Wolf B (2003) Neonatal screening for biotinidase deficiency in Hungary: clinical, biochemical and molecular studies. J Inherit Metab Dis 26:693–698
Li H, Spencer L, Nahhas F, Miller J, Fribley A, Feldman G, Conway R, Wolf B (2014) Novel mutations causing biotinidase deficiency in individuals identified by newborn screening in Michigan including an unique intronic mutation that alters mRNA expression of the biotinidase gene. Mol Genet Metab 112(3):242–246. doi:10.1016/j.ymgme.2014.04.002
Möslinger D, Stockler-Ipsiroglu S, Scheibenreiter S, Tiefenthaler M, Mühl A, Seidl R, Strobl W, Plecko B, Suormala T, Baumgartner ER (2001) Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. Eur J Pediatr 160:277–282
Möslinger D, Mühl A, Suormala T, Baumgartner R, Stockler-Ipsiroglu S (2003) Molecular characterisation and neuropsychological outcome of 21 patients with profound biotinidase deficiency detected by newborn screening and family studies. Eur J Pediatr 162:46–49. doi:10.1007/s00431-003-1351-3
Mühl A, Möslinger D, Item CB, Stockler-Ipsiroglu S (2001) Molecular characterization of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation. Eur J Hum Genet 9:237–243
Norrgard KJ, Pomponio RJ, Swango KL, Hymes J, Reynolds TR, Buck GA, Wolf B (1997) Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States. Biochem Mol Med 61(1):22–27
Norrgard KJ, Pomponio RJ, Swango KL, Hymes J, Reynolds T, Buck GA, Wolf B (1998) Double mutation [A171T and D444H] is a common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States. Hum Mutat 11:410. doi:10.1002/(SICI)1098-1004(1998)11:5<410::AID-HUMU10>3.0.CO;2-8
Norrgard KJ, Pomponio RJ, Hymes J, Wolf B (1999) Mutations causing profound biotinidase deficiency in children ascertained by newborn screening in the United States occur at different frequencies than in symptomatic children. Pediatr Res 46 (1):2 0–27
Ohlsson A, Guthenberg C, Holme E, von Dobeln U (2010) Profound biotinidase deficiency; a rare disease among native Swedes. J Inherit Metab Dis 33(Suppl3):175–180. doi:10.1007/s10545-010-9065-y
Pace HC, Brenner C (2001) The nitrilase superfamily: classification, structure and function. Genome Biol 2:1.1–1.9
Pindolia K, Jensen K, Wolf B (2007) Three dimensional structure of human biotinidase: computer modeling and functional correlations. Mol Genet Metab 92:13–22. doi:10.1016/j.ymgme.2007.04.013
Pindolia K, Jordan M, Wolf B (2010) Analysis of mutations causing biotinidase deficiency. Hum Mut 31(9):983–991. doi:10.1002/humu.21303
Pindolia K, Jordan M, Guo C, Matthews N, Mock DM, Strovel E, Blitzer M, Wolf B (2011) Development and characterization of a mouse with profound biotinidase deficiency: a biotin-responsive neurocutaneous disorder. Mol Genet Metab 102:161–169. doi:10.1016/j.ymgme.2010.10.005
Pindolia K, Chen J, Cardwell C, Cui X, Chopp M, Wolf B (2012) Neurological deficits in mice with profound biotinidase deficiency are associated with demylination and axonal degeneration. Neurobiol Dis 47:428–435. doi:10.1016/j.nbd.2012.04.016
Pomponio RJ, Hymes J, Reynolds TR, Meyers GA, Fleischhauer K, Buck GA, Wolf B (1997) Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical, and clinical analysis. Pediatr Res 42:840–848. doi:10.1203/00006450-199712000-00020
Pomponio RJ, Norrgard KJ, Hymes J, Reynolds TR, Reynolds TR, Buck GA, Baumgartner R, Suormala T, Wolf B (1997) Arg538 to Cys mutation in a CpG dinucleotide of the human biotinidase gene is the second most common cause of biotinidase deficiency in symptomatic children with biotinidase deficiency. Hum Genet 99:506–512
Pomponio RJ, Yamaguchi A, Arashima S, Hymes J, Wolf B (1998) Mutation in a putative glycosylation site (N489T) of biotinidase is the only known Japanese child with biotinidase deficiency. Mol Genet Metab 64:152–154. doi:10.1006/mgme.1998.2706
Pomponio RJ, Coskun T, Demirkol M, Tokatli A, Ozalp I, Hüner G, Baykal T, Wolf B (2000) Novel mutations cause biotinidase deficiency in Turkish children. J Inherit Metab Dis 23:120–128
Procter M, Wolf B, Crockett DK, Mao R (2013) The biotinidase gene variants registry: a paradigm public database. G3 (Bethesda) 3(4):727–731. doi:10.1534/g3.113.005835
Raha S, Udani V (2011) Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature. Pediatr Neurol 45:261–264. doi:10.1016/j.pediatrneurol.2011.06.010
Sarafoglou K, Bentler K, Gaviglio A, Redlinger-Grosse K, Anderson C, McCann M, Bloom B, Babovic-Vuksanovic D, Gavrilov D, Berry SA (2009) High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota. J Inherit Metab Dis 32(Suppl1):169–173. doi:10.1007/s10545-009-1135-7
Sivri HS, Genç GA, Tokatli A, Dursun A, Coşkun T, Aydin HI, Sennaroğlu L, Belgin E, Jensen K, Wolf B (2007) Hearing loss in biotinidase deficiency: genotype-phenotype correlation. J Pediatr 150 (4):4 39–442. DOI: 10.1016/j.jpeds.2007.01.036
Stanley CM, Hymes J, Wolf B (2004) Identification of alternatively spliced human biotinidase mRNAs and putative localization of endogenous biotinidase. Mol Genet Metab 81(4):300–312. doi:10.1016/j.ymgme.2003.12.006
Suzuki Y, Yang X, Aoki Y, Kure S, Matsubara Y (2005) Mutations in the holocarboxylase synthetase gene HLCS. Hum Mutat 26(4):285–290. doi:10.1002/humu.20204
Swango KL, Demirkol M, Huner G, Pronicka E, Sykut-Cegielska J, Schulze A, Wolf B (1998) Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene. Hum Genet 102:571–575
Swango KL, Wolf B (2001) Conservation of biotindase in mammals and identification of the putative biotinidase gene in Drosophila melanogaster. Mol Genet Metab 74:492–499. doi:10.1006/mgme.2001.3244
Thodi G, Schulpis KH, Molou E, Georgiou V, Loukas YL, Dotsikas Y, Papadopoulos K, Biti S (2013) High incidence of partial biotinidase deficiency cases in newborns of Greek origin. Gene 524:361–362. doi:10.1016/j.gene.2013.04.059
Winchester S, Singh PK, Mikati MA (2013) Ataxia. Handb Clin Neurol 112:1213–1217. doi:10.1016/B978-0-444-52910-7.00043-X
Wolf B, Heard GS (1990) Screening for biotinidase deficiency in newborns: worldwide experience. Pediatrics 85:512–517
Wolf B (1993) Biotinidase deficiency, In: Pagon RA, Bird TD, Dolan CR, Stephens K, (eds). GeneReviews
Wolf B, Pomponio RJ, Norrgard KJ, Lott IT, Baumgartner ER, Suormala T, RaemarkersVTh CT, Tokatlı A, Ozalp I, Hymes J (1998) Delayed-onset profound biotinidase deficiency. J Pediatr 132:362–365. doi:10.1016/S0022-3476(98)70464-0
Wolf B, Jensen K, Huner G, Demirkol M, Baykal T, Divry P, Rolland MO, Perez-Cerdá C, Ugarte M, Straussberg R, Basel-Vanagaite L, Baumgartner ER, Suormala T, Scholl S, Das AM, Schweitzer S, Pronicka E, Sykut-Cegielska J (2002) Seventeen novel mutations that cause profound biotinidase deficiency. Mol Genet Metab 77:108–111. doi:10.1016/S1096-7192(02)00149-X
Wolf B, Jensen KP, Barshop B, Blitzer M, Carlson M, Goudie DR, Gokcay GH, Demirkol M, Baykal T, Demir F, Quary S, Shih LY, Pedro HF, Chen TH, Slonim AE (2005) Biotinidase deficiency: novel mutations and their biochemical and clinical correlates. Hum Mutat 25:413. doi:10.1002/humu.9329
Wolf B, Jensen K (2005) Evolutionary conservation of biotinidase: implications for the enzyme’s structure and subcellular localization. Mol Genet Metab 86:44–50. doi:10.1016/j.ymgme.2005.07.011
Wolf B (2010) Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab 100:6–13. doi:10.1016/j.ymgme.2010.01.003
Wolf B (2011) The neurology of biotinidase deficiency. Mol Genet Metab 104:27–34. doi:10.1016/j.ymgme.2011.06.001
Ye J, Han LS, Qui WJ, Zhang HW, Zhang YF, Gao XL, Wang Y, Gu XF (2009) Diagnosis, treatment, follow-up and gene mutation analysis in four Chinese children with biotinidase deficiency. J Inherit Metab Dis 32(Suppl1):295–302. doi:10.1007/s10545-009-1238-1
Zempleni J, Kuroishi T (2012) Biotin. Adv Nutr 3(2):213–214. doi:10.3945/an.111.001305
Acknowledgments
We thank to Dr. Şefayet Karaca for the scientific contribution. We would like to thank to Esin Göksun and Ayşegül Ozantürk, and to the members of DNA Bank at Hacettepe University, for biobanking assistance. We are grateful to the patients and their families for their collaboration.
This work was funded by a grant from State Planning Organization of Turkey (Project number: DPT2006K1206400603).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Beat Steinmann
Revisions received: 07 February 2015/16 February 2015
Rights and permissions
About this article
Cite this article
Karaca, M., Özgül, R.K., Ünal, Ö. et al. Detection of biotinidase gene mutations in Turkish patients ascertained by newborn and family screening. Eur J Pediatr 174, 1077–1084 (2015). https://doi.org/10.1007/s00431-015-2509-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-015-2509-5